NCT05002244 - A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

August 29, 2021

Study Completion Date

September 13, 2021

Conditions

Health, Subjective

Interventions

DRUG

CTL0801 (Azilsartan)

CTL0801 (Azilsartan), single dose, daily, repeated oral administration

DRUG

CTL0802 (Rosuvastatin)

CTL0802 (Rosuvastatin), single dose, daily, repeated oral administration

DRUG

CTL0801 (Azilsartan) + CTL0802 (Rosuvastatin)

CTL0801 (Azilsartan) + CTL0802 (Rosuvastatin), single dose, daily, repeated oral administration

Trial Locations (1)

H Plus Yangji Hospital, Seoul